<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36918362</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>02</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Physical activity as an exogenous risk factor for amyotrophic lateral sclerosis: a review of the evidence.</ArticleTitle><Pagination><StartPage>1745</StartPage><EndPage>1757</EndPage><MedlinePgn>1745-1757</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awac470</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a rapidly progressive and fatal neurodegenerative disorder. The only established epidemiological risk factors for ALS are male sex and increasing age. The role of physical activity has been debated as an environmental risk factor. Over the last decade multiple studies have attempted to delineate the architecture of ALS. These have not yet established definite risk factors, often due to low-powered studies, lack of focus on at-risk genotypes and sub-optimal methodology. We have conducted a review of all the studies published between 2009 and December 2021. The free text search terms were [(motor neuron disease) OR (MND) OR (Amyotrophic Lateral Sclerosis) OR (ALS)] AND [(Exercise) or (Physical Activity) or (PA) or (sport)]. We identified common themes, for example soccer, head injury and the physiological mechanisms that differ in ALS patients. We have analysed the relevant, available studies (n = 93), highlighting the underlying reasons for any reported discrepancies. Overall, we have found that the more highly powered studies using validated exposure methodologies, linked strenuous, anaerobic physical activity as a risk factor for ALS. Future large-scale studies focusing on specific at-risk genotypes and physical activity should be conducted to confirm this finding. This will strengthen the evidence already surrounding strenuous physical activity as an environmental risk factor for ALS and allow advice to be given to at-risk family members. Increasing our understanding of the genetic-environmental interactions in the pathophysiology of ALS will allow for the possibility of developing preventative therapeutic approaches.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chapman</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6174-9435</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper-Knock</LastName><ForeName>Johnathan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0873-8689</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Pamela J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-8925-2567</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BRC-1215-20017</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>216596/Z/19/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>NF-SI-0617-10077</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">environmental risk factor</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">strenuous physical activity</Keyword></KeywordList><CoiStatement>The authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36918362</ArticleId><ArticleId IdType="pmc">PMC10151186</ArticleId><ArticleId IdType="doi">10.1093/brain/awac470</ArticleId><ArticleId IdType="pii">7077743</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The red flag tool for diagnosis motor neurone disease. British Geriatrics Society. Accessed 15 April 2021. https://www.bgs.org.uk/blog/the-red-flag-tool-for-diagnosing-motor-neurone-disease.</Citation></Reference><Reference><Citation>Saleem U, Sabir S, Gul Niazi S, Naeem M, Ahmad B. Role of oxidative stress and antioxidant defense biomarkers in neurodegenerative diseases. Crit Rev Eukaryot Gene Expr. 2020;30:311&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">32894661</ArticleId></ArticleIdList></Reference><Reference><Citation>
Basic Facts about MND. Motor Neurone Disease Association. Accessed 16 April 2021. www.mndassociation.org/about-mnd/what-is-mnd/basic-facts-about-mnd/.</Citation></Reference><Reference><Citation>Logroscino G, Piccininni M, Marin B, et al. . Global, regional, and national burden of motor neuron diseases 1990-2016: A systematic analysis for the global burden of disease study 2016. The Lancet Neurology. 2018;17:1083&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6234315</ArticleId><ArticleId IdType="pubmed">30409709</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Jenkins T, Shaw PJ. Clinical and molecular aspects of motor neuron disease. Vol. 2. Morgan &amp; Claypool Publishers; 2013.</Citation></Reference><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS: A conspiracy of genes, environment and time. Nature Reviews Neurology. 2013;9:617&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley WG, Miller RX, Levine TD, Stommel EW, Cox PA. Studies of environmental risk factors in amyotrophic lateral sclerosis (ALS) and a phase I clinical trial of L-serine. Neurotox Res. 2018;33:192&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">28527102</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuraszkiewicz B, Goszczy&#x144;ska H, Podsiad&#x142;y-Marczykowska T, et al. . Potential preventive strategies for amyotrophic lateral sclerosis. Front Neurosci. 2020;14:428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264408</ArticleId><ArticleId IdType="pubmed">32528241</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Calvo A, Chio A, et al. . Analysis of amyotrophic lateral sclerosis as a multistep process: A population-based modelling study. Lancet Neurol. 2014;13:1108&#x2013;1113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Hewitt C, Highley JR, et al. . Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain. 2012;135(Pt 3):751&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E, Renton AE, Mok K, et al. . Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study. Lancet Neurol. 2012;11:323&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Niccoli T, Partridge L, Isaacs AM. Ageing as a risk factor for ALS/FTD. Hum Mol Genet. 2017;26(R2):R105&#x2013;R113.</Citation><ArticleIdList><ArticleId IdType="pubmed">28977441</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Calvo A, Dossena M, Ghiglione P, Mutani R, Mora G. ALS In Italian professional soccer players: The risk is still present and could be soccer-specific. Amyotroph Lateral Scler. 2009;10:205&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">19267274</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson P, L&#xf6;nnstedt I, Nygren I, Askmark H. Physical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early age. J Neurol Neurosurg Psychiatry. 2012;83:390&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">20852312</ArticleId></ArticleIdList></Reference><Reference><Citation>Savica R, Parisi JE, Wold LE, Josephs KA, Ahlskog JE. High school football and risk of neurodegeneration: A community-based study. Mayo Clin Proc. 2012;87:335&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3538465</ArticleId><ArticleId IdType="pubmed">22469346</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Su FC, Callaghan BC, Goutman SA, Batterman SA, Feldman EL. Environmental risk factors and amyotrophic lateral sclerosis (ALS): A case-control study of ALS in Michigan. PLoS One. 2014;9:e101186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4076303</ArticleId><ArticleId IdType="pubmed">24979055</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen PHH, Mandrekar J, Mielke MM, et al. . High school football and late-life risk of neurodegenerative syndromes, 1956-1970. Mayo Clin Proc. 2017;92:66&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5452974</ArticleId><ArticleId IdType="pubmed">27979411</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani AS, Gandhavadi M, Jena AB. Association between playing American football in the national football league and long-term mortality. JAMA. 2018;319:800&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5838566</ArticleId><ArticleId IdType="pubmed">29392304</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood CA, McDermott CJ, Shaw PJ. Physical activity as an exogenous risk factor in motor neuron disease (MND): A review of the evidence. Amyotroph Lateral Scler. 2009;10:191&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">19263258</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystoriak MA, Bhatnagar A. Cardiovascular effects and benefits of exercise. Front Cardiovasc Med. 2018;5:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6172294</ArticleId><ArticleId IdType="pubmed">30324108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacorte E, Ferrigno L, Leoncini E, Corbo M, Boccia S, Vanacore N. Physical activity, and physical activity related to sports, leisure, and occupational activity as risk factors for ALS: A systematic review. Neuroscience &amp; Biobehavioral Reviews. 2016;66:61&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">27108217</ArticleId></ArticleIdList></Reference><Reference><Citation>Daneshvar DH, Mez J, Alosco ML, et al. . Incidence of and mortality from amyotrophic lateral sclerosis in national football league athletes. JAMA Network Open. 2021;4:e2138801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674746</ArticleId><ArticleId IdType="pubmed">34910152</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond J, Mehta P, Larson T, Factor-Litvak P, Davis B, Horton K. History of vigorous leisure-time physical activity and early onset amyotrophic lateral sclerosis (ALS), data from the national ALS registry: 2010&#x2013;2018. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2021;22(7&#x2013;8):535&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8559906</ArticleId><ArticleId IdType="pubmed">33896281</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamez J, Carmona F. Confirmation of early non-bulbar onset of amyotrophic lateral sclerosis in spanish league soccer players. J Neurol Sci. 2021;428:117586.</Citation><ArticleIdList><ArticleId IdType="pubmed">34343861</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell ER, Mackay DF, Stewart K, MacLean JA, Pell JP, Stewart W. Association of field position and career length with risk of neurodegenerative disease in Male former professional soccer players. JAMA Neurol. 2021;78:1057&#x2013;1063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8329793</ArticleId><ArticleId IdType="pubmed">34338724</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian TH, Glascow N, Barry ADF, et al. . Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes. EBioMedicine. 2021;68:103397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8170114</ArticleId><ArticleId IdType="pubmed">34051439</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, van Veenhuijzen K, van der Spek RA, et al. . Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: A longitudinal, population-based, case-control study. Lancet Neurol. 2021;20:373&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">33894192</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A, D&#x2019;Ovidio F, Calvo A, et al. . Lifetime sport practice and brain metabolism in amyotrophic lateral sclerosis. Neuroimage Clin. 2020;27:102312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334468</ArticleId><ArticleId IdType="pubmed">32622315</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F, H&#xe5;llmarker U, James S, et al. . Amyotrophic lateral sclerosis among cross-country skiers in Sweden. Eur J Epidemiol. 2016;31:247&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">26220522</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood CA, Westgate K, Gunstone S, et al. . Long-term physical activity: An exogenous risk factor for sporadic amyotrophic lateral sclerosis? Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(5&#x2013;6):377&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4950417</ArticleId><ArticleId IdType="pubmed">26998882</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquinelli A, Chico L, Pasquali Let al. . Gly482Ser PGC-1&#x3b1; gene polymorphism and exercise-related oxidative stress in amyotrophic lateral sclerosis patients. Front Cell Neurosci. 2016;10:102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4840260</ArticleId><ArticleId IdType="pubmed">27147974</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehman EJ, Hein MJ, Baron SL, Gersic CM. Neurodegenerative causes of death among retired national football league players. Neurology. 2012;79:1970&#x2013;1974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098841</ArticleId><ArticleId IdType="pubmed">22955124</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Wicks P, Brownstein CA, et al. . Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:853&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">20562391</ArticleId></ArticleIdList></Reference><Reference><Citation>Korner S, Kammeyer J, Zapf A, et al. . Influence of environment and lifestyle on incidence and progress of amyotrophic lateral sclerosis in A German ALS population. Aging Dis. 2019;10:205&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6457054</ArticleId><ArticleId IdType="pubmed">31011473</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: Definitions and distinctions for health-related research. Public Health Rep. 1985;100:126&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1424733</ArticleId><ArticleId IdType="pubmed">3920711</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel H, Alkhawam H, Madanieh R, Shah N, Kosmas CE, Vittorio TJ. Aerobic vs anaerobic exercise training effects on the cardiovascular system. World J Cardiol. 2017;9:134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5329739</ArticleId><ArticleId IdType="pubmed">28289526</ArticleId></ArticleIdList></Reference><Reference><Citation>Besson H, Harwood CA, Ekelund U, et al. . Validation of the historical adulthood physical activity questionnaire (HAPAQ) against objective measurements of physical activity. International Journal of Behavioral Nutrition and Physical Activity. 2010;7:54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2902409</ArticleId><ArticleId IdType="pubmed">20576086</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Driscoll R, Turicchi J, Beaulieu K, et al. . How well do activity monitors estimate energy expenditure? A systematic review and meta-analysis of the validity of current technologies. Br J Sports Med. 2020;54:332&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">30194221</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian T, Boddy S, Islam M, et al. . A review of Mendelian randomization in amyotrophic lateral sclerosis. Brain. 2022;145:832&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9050546</ArticleId><ArticleId IdType="pubmed">34791088</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordesj&#xf6; LO, Sch&#xe9;le R. Validity of an ergometer cycle test and measures of isometric muscle strength when prediction some aspects of military performance. Swedish J Defence Med. 1974;10:11&#x2013;23.</Citation></Reference><Reference><Citation>Sporis G, Ruzic L, Leko G. The anaerobic endurance of elite soccer players improved after a high-intensity training intervention in the 8-week conditioning program. The Journal of Strength &amp; Conditioning Research. 2008;22:559&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">18550974</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CJ, Beard KK, Cartmill JB. Mortality in chemical workers potentially exposed to 2,4-dichlorophenoxyacetic acid (2,4-D) 1945&#x2013;94: An update. Occup Environ Med. 2001;58:24-&#x2013;30..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1740039</ArticleId><ArticleId IdType="pubmed">11119631</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicks P, Ganesalingham J, Collin C, Prevett M, Leigh NP, Al-Chalabi A. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:177&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">17538780</ArticleId></ArticleIdList></Reference><Reference><Citation>Morahan JM, Yu B, Trent RJ, Pamphlett R. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis. Neurotoxicology. 2007;28:532&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">17204329</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini T, Fiore M, Tesauro M, et al. . Clinical and lifestyle factors and risk of amyotrophic lateral sclerosis: A population-based case-control study. Int J Environ Res Public Health. 2020;17:857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7037077</ArticleId><ArticleId IdType="pubmed">32019087</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo CH, Seo DI. Analysis of physical fitness and technical skills of youth soccer players according to playing position. J Exerc Rehabil. 2016;12:548&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5227316</ArticleId><ArticleId IdType="pubmed">28119876</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M, Conforti FL, Zollino M, et al. . C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol Aging. 2012;33:1848.e15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372681</ArticleId><ArticleId IdType="pubmed">22418734</ArticleId></ArticleIdList></Reference><Reference><Citation>Losnegard T. Energy system contribution during competitive cross-country skiing. Eur J Appl Physiol. 2019;119:1675&#x2013;1690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6647095</ArticleId><ArticleId IdType="pubmed">31076890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol. 2003;53:804&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">12783429</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Gavett BE, Stern RA, et al. . TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol. 2010;69:918&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2951281</ArticleId><ArticleId IdType="pubmed">20720505</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al. . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford JH, Giovanello KS, Guskiewicz KM. Episodic memory in former professional football players with a history of concussion: An event-related functional neuroimaging study. J Neurotrauma. 2013;30:1683&#x2013;1701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3840476</ArticleId><ArticleId IdType="pubmed">23679098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart JJ, Kraut MA, Womack KB, et al. . Neuroimaging of cognitive dysfunction and depression in aging retired national football league players: A cross-sectional study. JAMA Neurol. 2013;70:326&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4016798</ArticleId><ArticleId IdType="pubmed">23303193</ArticleId></ArticleIdList></Reference><Reference><Citation>Randolph C, Karantzoulis S, Guskiewicz K. Prevalence and characterization of mild cognitive impairment in retired national football league players. J Int Neuropsychol Soc. 2013;19:873&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pubmed">23902607</ArticleId></ArticleIdList></Reference><Reference><Citation>Contrepois K, Wu S, Moneghetti KJ, et al. . Molecular choreography of acute exercise. Cell. 2020;181:1112&#x2013;1130.e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299174</ArticleId><ArticleId IdType="pubmed">32470399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, De Bono JP, Heath PR, et al. . Transcriptional response of the neuromuscular system to exercise training and potential implications for ALS. J Neurochem. 2009;109:1714&#x2013;1724.</Citation><ArticleIdList><ArticleId IdType="pubmed">19344372</ArticleId></ArticleIdList></Reference><Reference><Citation>Fidler JA, Treleaven CM, Frakes A, et al. . Disease progression in a mouse model of amyotrophic lateral sclerosis: The influence of chronic stress and corticosterone. FASEB J. 2011;25:4369&#x2013;4377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3236626</ArticleId><ArticleId IdType="pubmed">21876068</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho S, Lee H, Lee HY, Kim SJ, Song W. The effect of fibroblast growth factor receptor inhibition on resistance exercise training-induced adaptation of bone and muscle quality in mice. Korean J Physiol Pharmacol. 2022;26:207&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046891</ArticleId><ArticleId IdType="pubmed">35477548</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall JM, Gomez-Pinilla F, Savage LM. Nerve growth factor is responsible for exercise-induced recovery of septohippocampal cholinergic structure and function. Front Neurosci. 2018;12:773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6222249</ArticleId><ArticleId IdType="pubmed">30443202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K, Honda A, Hayashi Y, Inuzuka T, Satoh M, Hozumi I. DNA Microarray analysis of transcriptional responses of mouse spinal cords to physical exercise. J Toxicol Sci. 2009;34:445&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pubmed">19652469</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbeito LH, Pehar M, Cassina P, et al. . A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev. 2004;47(1&#x2013;3):263&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">15572176</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassina P, Pehar M, Vargas MR, et al. . Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: Implications for amyotrophic lateral sclerosis. J Neurochem. 2005;93:38&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">15773903</ArticleId></ArticleIdList></Reference><Reference><Citation>Amar D, Lindholm ME, Norrbom J, Wheeler MT, Rivas MA, Ashley EA. Time trajectories in the transcriptomic response to exercise - a meta-analysis. Nat Commun. 2021;12:3471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8190306</ArticleId><ArticleId IdType="pubmed">34108459</ArticleId></ArticleIdList></Reference><Reference><Citation>Burguete AS, Almeida S, Gao FB, Kalb R, Akins MR, Bonini NM. GGGGCC Microsatellite RNA is neuritically localized, induces branching defects, and perturbs transport granule function. Elife. 2015;4:e08881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4758954</ArticleId><ArticleId IdType="pubmed">26650351</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher L, Culver D, Tennant P, et al. . Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp Neurol. 2004;185:232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>De Winter F, Vo T, Stam F, et al. . The expression of the chemorepellent semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol Cell Neurosci. 2006;32(1&#x2013;2):102&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">16677822</ArticleId></ArticleIdList></Reference><Reference><Citation>Karpati G, Hilton-Jones D, Bushby K, Griggs RC. Disorders of voluntary muscle. 8th ed. Cambridge University Press; 2010.</Citation></Reference><Reference><Citation>Nijssen J, Comley LH, Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragagnin AMG, Shadfar S, Vidal M, Jamali MS, Atkin JD. Motor neuron susceptibility in ALS/FTD. Front Neurosci. 2019;13:532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6610326</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza S, Salvatori I, Giacovazzo G, et al. . Skeletal-Muscle metabolic reprogramming in ALS-SOD1(G93A) mice predates disease onset and is a promising therapeutic target. iScience. 2020;23:101087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200935</ArticleId><ArticleId IdType="pubmed">32371370</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassini A, Cameron LC. Sportomics: Building a new concept in metabolic studies and exercise science. Biochem Biophys Res Commun. 2014;445:708&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pubmed">24406165</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardiner P, Dai Y, Heckman CJ. Effects of exercise training on alpha-motoneurons. J Appl Physiol. 2006;101:1228&#x2013;1236.</Citation><ArticleIdList><ArticleId IdType="pubmed">16778002</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink JH, B&#xe4;r PR, Joosten EAJ, Otten M, Wokke JHJ, van den Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord. 2003;13:737&#x2013;743.</Citation><ArticleIdList><ArticleId IdType="pubmed">14561497</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebetanz D, Hagemann K, von Lewinski F, Kahler E, Paulus W. Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur J Neurosci. 2004;20:3115&#x2013;3120.</Citation><ArticleIdList><ArticleId IdType="pubmed">15579165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Heath PR, Holden H, Kasher PR, Kirby J, Shaw PJ. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J Neuroscience. 2007;27:9201&#x2013;9219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6672214</ArticleId><ArticleId IdType="pubmed">17715356</ArticleId></ArticleIdList></Reference><Reference><Citation>Deforges S, Branchu J, Biondi Oet al. . Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol. 2009;587:3561&#x2013;3572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742281</ArticleId><ArticleId IdType="pubmed">19491245</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber N, Shaw PJ. Biomarkers in amyotrophic lateral sclerosis: A review of new developments. Curr Opin Neurol. 2020;33:662&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pubmed">32796280</ArticleId></ArticleIdList></Reference><Reference><Citation>Long J, Liu C, Sun L, Gao H, Liu J. Neuronal mitochondrial toxicity of malondialdehyde: Inhibitory effects on respiratory function and enzyme activities in rat brain mitochondria. Neurochem Res. 2009;34:786&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pubmed">19023656</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi S, Abramov AY. Mechanism of oxidative stress in neurodegeneration. Ksiazek K, ed. Oxid Med Cell Longev. 2012;2012:428010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3362933</ArticleId><ArticleId IdType="pubmed">22685618</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y, Yin X, Wang S, et al. . PGC-1&#x3b1; Silencing compounds the perturbation of mitochondrial function caused by mutant SOD1 in skeletal muscle of ALS mouse model. Front Aging Neurosci. 2015;7:204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4611176</ArticleId><ArticleId IdType="pubmed">26539112</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng SW, Lin TK, Wang PW, et al. . Gly482Ser polymorphism in the peroxisome proliferator-activated receptor &#x3b3; coactivator-1&#x3b1; gene is associated with oxidative stress and abdominal obesity. Metab Clin Exp. 2010;59:581&#x2013;586.</Citation><ArticleIdList><ArticleId IdType="pubmed">19913841</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewerenz J, Maher P. Chronic glutamate toxicity in neurodegenerative diseases&#x2014;What is the evidence? Front Neurosci. 2015;9:469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4679930</ArticleId><ArticleId IdType="pubmed">26733784</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss JH. Ca permeable AMPA channels in diseases of the nervous system. Front Mol Neurosci. 2011;4:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3214733</ArticleId><ArticleId IdType="pubmed">22102834</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy NA, Arthur KC, Tienari PJ, Houlden H, Chi&#xf2; A, Traynor BJ. Age-related penetrance of the C9orf72 repeat expansion. Sci Rep. 2017;7:2116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5437033</ArticleId><ArticleId IdType="pubmed">28522837</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook A, McEwen A, Fifita JA, et al. . The C9orf72 hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counselling. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2019;20(5&#x2013;6):310&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">30907153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastos AF, Orsini M, Machado D, et al. . Amyotrophic lateral sclerosis: One or multiple causes? Neurol Int. 2011;3:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3141115</ArticleId><ArticleId IdType="pubmed">21785676</ArticleId></ArticleIdList></Reference><Reference><Citation>Oggiano R, Solinas G, Forte G, et al. . Trace elements in ALS patients and their relationships with clinical severity. Chemosphere. 2018;197:457&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">29366958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XR, Prudencio M, Koike Y, et al. . TDP-43 represses cryptic exon inclusion in the FTD&#x2013;ALS gene UNC13A. Nature. 2022;603:124&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk TR, Rousseaux MWC. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener. 2020;15:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. Journal of Neuroscience. 2010;30:639&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CH, Davidson S, Harapas CR, et al. . TDP-43 Triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell. 2020;183:636&#x2013;649.e18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Green C, Altschuler G, et al. . A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2017;5:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5353945</ArticleId><ArticleId IdType="pubmed">28302159</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W, Shatunov A, Dekker AM, et al. . Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48:1043&#x2013;1048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>West RJH, Sharpe JL, Voelzmann A, et al. . Co-expression of C9orf72 related dipeptide-repeats over 1000 repeat units reveals age-specific and combination-specific phenotypic profiles in drosophila. Acta Neuropathol Commun. 2020;8:158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7487709</ArticleId><ArticleId IdType="pubmed">32894207</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattamatta A, Nguyen L, Olafson HR, et al. . Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice. Hum Mol Genet. 2021;29:3900&#x2013;3918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906756</ArticleId><ArticleId IdType="pubmed">33378537</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw MP, Higginbottom A, McGown A, et al. . Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features. Acta Neuropathol Commun. 2018;6:125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240957</ArticleId><ArticleId IdType="pubmed">30454072</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L, Montrasio F, Pattamatta A, et al. . Antibody therapy targeting RAN proteins rescues C9 ALS/FTD phenotypes in C9orf72 mouse model. Neuron. 2020;105:645&#x2013;662.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391607</ArticleId><ArticleId IdType="pubmed">31831332</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>